Dr John Prendergast

RCE

Insider activity · 24 months1 buy0 salesCumulative net flow

Dec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 1 buy · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 salesNov 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 06 Aug 2026 for RCE, €0.

Filing timeline

BuySale

Dr John Prendergast

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Dr John Prendergast: trading record in brief

Only one filing by Dr John Prendergast is known so far (6 August 2026): an open-market purchase, in Recce Pharmaceuticals Ltd. That is too little to draw conclusions. Source: insider filings from ASX. Past trades are no guide to future returns.

Companies and markets linked to Dr John Prendergast

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

RCE (AU)

Declarations1 total

▲
Dr John Prendergast
DirectorExecutives31 Jul 2026RCE
0 AUD0ASX
37,500 sharesShareASXASX:2924-03118712-6A1337631
Canonical exit: 29 Oct 2026 (T+90)

1 of 1 declaration

Dr John Prendergast

Insider track record

Dr John Prendergast: trading record in brief

Companies and markets linked to Dr John Prendergast

Related entities